Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 1;68(11):e173-e178.
doi: 10.1097/MAT.0000000000001820. Epub 2022 Oct 12.

Bioprosthetic Total Artificial Heart Implantation Does Not Induce Chronic Inflammation

Affiliations

Bioprosthetic Total Artificial Heart Implantation Does Not Induce Chronic Inflammation

Christophe Peronino et al. ASAIO J. .

Abstract

The Aeson total artificial heart (A-TAH) has been developed for patients at risk of death from biventricular failure. We aimed to assess the inflammatory status in nine subjects implanted with the A-TAH in kinetics over one year. Laboratory assessment of leukocyte counts, inflammatory cytokines assay, and peripheral blood mononuclear cell collection before and after A-TAH implantation. Leukocyte counts were not significantly modulated according to time after A-TAH implantation (coefficient of the linear mixed effect model with 95% CI, -0.05 (-0.71 to -0.61); p = 0.44). We explored inflammatory cytokine after A-TAH and did not observe, at any time, a modified profile compared to pre-implantation values (all p -values > 0.05). Finally, we compared the distribution of circulating immune cell subpopulations identified based on sequential expression patterns for multiple clusters of differentiation. None of the population explored had significant modulation during the 12-month follow-up (all p -values > 0.05). In conclusion, using a cytokine multiplex assay combined with a flow cytometry approach, we demonstrated the absence of inflammatory signals in peripheral blood over a period of 12 months following A-TAH implantation.

PubMed Disclaimer

Conflict of interest statement

D.M.S., P.I., Y.P. and I.N. received consulting fees from CARMAT. C.P., C.L., A.C. and P.J. are employed by CARMAT-SAS. Other authors have no conflicts of interest to report.

References

    1. Ankersmit HJ, Tugulea S, Spanier T, et al.: Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet. 354: 550–555, 1999.
    1. Deng MC, Erren M, Tjan TD, et al.: Left ventricular assist system support is associated with persistent inflammation and temporary immunosuppression. Thorac Cardiovasc Surg. 47(suppl 2): 326–331, 1999.
    1. Granja T, Magunia H, Schussel P, Fischer C, Prufer T, Schibilsky D, et al.: Left ventricular assist device implantation causes platelet dysfunction and proinflammatory platelet-neutrophil interaction. Platelets. 33: 132–140, 2022.
    1. Sciaccaluga C, Ghionzoli N, Mandoli GE, et al.: Biomarkers in patients with left ventricular assist device: An insight on current evidence. Biomolecules. 12: 334, 2022.
    1. Woolley JR, Teuteberg JJ, Bermudez CA, et al.: Temporal leukocyte numbers and granulocyte activation in pulsatile and rotary ventricular assist device patients. Artif Organs. 38: 447–455, 2014.

Publication types